Jans Verna, Dondorp Wybo, Goossens Ellen, Mertes Heidi, Pennings Guido, de Wert Guido
Department of Health, Ethics and Society and Research School GROW for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Department of Biology of the Testis (BITE), Vrije Universiteit Brussel, Brussels, Belgium.
Med Health Care Philos. 2018 Dec;21(4):537-545. doi: 10.1007/s11019-018-9827-0.
In the field of medically assisted reproduction (MAR), there is a growing emphasis on the importance of introducing new assisted reproductive technologies (ARTs) only after thorough preclinical safety research, including the use of animal models. At the same time, there is international support for the three R's (replace, reduce, refine), and the European Union even aims at the full replacement of animals for research. The apparent tension between these two trends underlines the urgency of an explicit justification of the use of animals for the development and preclinical testing of new ARTs. Considering that the use of animals remains necessary for specific forms of ART research and taking account of different views on the moral importance of helping people to have a genetically related child, we argue that, in principle, the importance of safety research as part of responsible innovation outweighs the limited infringement of animal wellbeing involved in ART research.
在医学辅助生殖(MAR)领域,人们越来越强调只有在进行全面的临床前安全性研究(包括使用动物模型)之后才引入新的辅助生殖技术(ARTs)的重要性。与此同时,国际上支持“3R原则”(替代、减少、优化),欧盟甚至旨在完全替代用于研究的动物。这两种趋势之间明显的矛盾凸显了明确说明在新ARTs的开发和临床前测试中使用动物的必要性的紧迫性。考虑到在特定形式的ART研究中使用动物仍然是必要的,并考虑到对于帮助人们生育有基因关联孩子的道德重要性的不同观点,我们认为,原则上,作为负责任创新一部分的安全性研究的重要性超过了ART研究中对动物福利的有限侵犯。